Understanding the transformative impact of ICH E6(R3) guidelines on clinical trial oversight and quality management.
ADAMAS
Key Updates in ICH E6(R3) & Implementation Steps Introduction
In this free guide, we break down the most critical updates to ICH E6(R3)—and provide practical, inspection-ready strategies to help you stay compliant, audit-ready, and ahead of regulatory expectations.
ADAMAS Consulting’s proven Risk-Based Quality Assurance (RBQA) process
ADAMAS Consulting’s proven Risk-Based Quality Assurance (RBQA) process—designed to help sponsors meet the evolving requirements of ICH E6 (R3) with confidence
Target your risk where it lies: At the leading edge of risk-based strategy
Discover how ADAMAS helped a sponsor prepare for inspection using a targeted risk-based approach
On Demand Webinar: GCP ICH E6 R3 Unveiled: Navigating the Evolving Roles of Sponsors and CROs
ADAMAS Consulting’s webinar, “GCP ICH E6 R3 Unveiled: Navigating the Evolving Roles of Sponsors and CROs,” provides invaluable insights into the evolving landscape of Good Clinical Practice (GCP) guidelines. Experts discuss key updates to ICH E6 R3 and how Sponsors...
Insights and Compliance Strategies for Pharmacovigilance Under the Windsor Framework
Understand key Windsor Framework changes for UK pharmacovigilance in 2025 and how MAHs can stay compliant under new MHRA rules
Recent Posts
Clinical Quality Roundtable Series 2026 | USA
WEBINAR | “Designing Risk-Based QA Oversight for Clinical Trials Under ICH E6 (R3)”
Society of Quality Assurance (SQA) Annual Meeting 2026 | Maryland, USA
ICH E6 R3 — One Year On: From Regulatory Update to Operational Transformation
AURA: Revolutionizing Risk-Based Audit Planning in Pharmacovigilance